LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic pain.

por Cleverton K F Lima, Rafael M Silva, Renata B Lacerda, Bruna L R Santos, Rafaela V Silva, Luciana S Amaral, Luís E M Quintas, Carlos A M Fraga, Eliezer J Barreiro, Marília Z P Guimaraes, Ana L P Miranda
Publicado 2014